Eris Lifesciences has informed that the Company has given a corporate guarantee in favour of Eris Therapeutics Limited ('ETL'), a Wholly Owned Subsidiary, for securing the term loan facility that it availed from Citi Bank N.A. Further, in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with Para B (11) of Part A to the Schedule III of the Listing Regulations and circular issued by the Securities and Exchange Board of India vide no. CIR/CFD/CMD/4/2015 dated September 9, 2015, details attached.
The above information is a part of company’s filings submitted to BSE.
